background image

Stem Cells Clinical Trials

Find clinical trials for stem cells. Search for stem cells clinical trials in different cities and states across the United States.

e.g. Respiratory Diseases
e.g. MassachusettsHealthy volunteers: No

Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics

Recruiting
PHASE1

Sponsor:

medac GmbH

Location:

Chicago, New York, Columbus, Richmond

Code:

NCT05534620

Conditions

Acute Myeloid Leukaemia (AML)

Myelodysplastic Syndrome (MDS)

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

T

r

e

o

s

Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes

Recruiting
PHASE2
PHASE3

Sponsor:

Throne Biotechnologies Inc.

Location:

Hackensack, Paramus

Code:

NCT04011020

Conditions

Type 1 Diabetes

Eligibility Criteria

Sex: All

Age: 14+

Healthy Volunteers: Not accepted

Interventions

S

t

e

m

Recruiting

Sponsor:

0

Eligibility Criteria

Sex:

Age: 0 - 70+

Healthy Volunteers: Not accepted

Allogeneic Hematopoietic Stem Cell Transplantation With JSP191-Based Conditioning in Participants With GATA2 Deficiency

Recruiting
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Bethesda

Code:

NCT05907746

Conditions

GATA2

Immunodeficiency

Eligibility Criteria

Sex: All

Age: 6 - 70

Healthy Volunteers: Not accepted

Interventions

M

y

c

o

p

90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome

Recruiting
PHASE1

Sponsor:

City of Hope Medical Center

Location:

Duarte

Code:

NCT05139004

Conditions

Acute Lymphoblastic Leukemia

Acute Myeloid Leukemia

Myelodysplastic Syndrome

Secondary Acute Myeloid Leukemia

Eligibility Criteria

Sex: All

Age: 60+

Healthy Volunteers: Not accepted

Interventions

A

l

o

g

e

A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant

Recruiting
PHASE2

Sponsor:

Memorial Sloan Kettering Cancer Center

Location:

New York

Code:

NCT05393804

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

I

d

e

-

c

Minimizing Toxicity in HLA-identical Related Donor Transplantation for Children With Sickle Cell Disease

Recruiting
PHASE2

Sponsor:

Robert Nickel

Location:

Washington, Chicago, Charlotte, Columbus

Code:

NCT03587272

Conditions

Sickle Cell Disease

Eligibility Criteria

Sex: All

Age: 2 - 25

Healthy Volunteers: Not accepted

Interventions

A

l

e

m

t

Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis

Recruiting
PHASE1
PHASE2

Sponsor:

Q Therapeutics, Inc.

Location:

Dallas

Code:

NCT03887273

Conditions

Transverse Myelitis

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Q

-

C

e

l

Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes

Recruiting
PHASE2

Sponsor:

Fred Hutchinson Cancer Center

Location:

Seattle

Code:

NCT03399773

Conditions

Acute Biphenotypic Leukemia

Acute Lymphoblastic Leukemia

Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Hematopoietic and Lymphoid Cell Neoplasm

Myelodysplastic Syndrome

Eligibility Criteria

Sex: All

Age: 10 - 65

Healthy Volunteers: Not accepted

Interventions

D

i

l

a

n

Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor Hematopoietic Stem Cell Transplants Who Have Rejected Their First Allogeneic Stem Cell Transplant

Recruiting
PHASE2

Sponsor:

Colorado Blood Cancer Institute

Location:

Denver

Code:

NCT00472329

Conditions

Graft Failure

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

A

l

o

g

e

What are stem cell clinical trials?

Stem cell clinical trials are research studies that explore the therapeutic potential of stem cells for treating a wide range of diseases and conditions. These trials investigate various types of stem cells, including embryonic stem cells, induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), and adipose-derived stem cells. These trials aim to develop treatments for a wide range of conditions, such as cardiovascular diseases, neurological disorders, autoimmune diseases, orthopedic injuries, Alzheimer's disease, Crohn's disease and cancer.

Importance of clinical trials for stem cells

Clinical trials for stem cells are crucial for advancing regenerative medicine and offering hope for patients with conditions that are currently difficult to treat. These studies help to determine the safety, efficacy, and optimal use of stem cell therapies, potentially leading to breakthroughs in the treatment of chronic diseases, immune disorders, and injuries. They play a vital role in understanding how stem cells can be used to repair damaged tissues, treat malignancies, and improve patient outcomes.

Types of interventions studied in stem cells clinical trials

Stem cell clinical trials investigate a variety of interventions aimed at utilizing the unique properties of stem cells for therapeutic purposes. Some common types of interventions studied in stem cell clinical trials include:

Allogeneic and autologous stem cell transplantation

These trials assess the use of stem cells derived from both the patient (autologous) and donors (allogeneic) for the treatment of hematologic diseases, solid tumors, and immune disorders, aiming to restore normal cell function and immune response.

Cell replacement therapies

Some trials focus on using stem cells to replace or repair damaged or dysfunctional cells or tissues in the body. For example, mesenchymal stem cells (MSCs) may be used to regenerate bone, cartilage, or muscle tissue in orthopedic conditions, while hematopoietic stem cell transplants are used to replace damaged blood-forming cells in conditions such as leukemia or aplastic anemia.

Tissue engineering and regenerative medicine

Clinical trials are investigating stem cells for their potential to stimulate tissue regeneration and repair. This includes approaches such as seeding stem cells onto scaffolds or matrices to create tissue-engineered constructs for transplantation. Research includes developing bioengineered tissues and organs using stem cells to replace damaged tissues in conditions like Crohn's disease-related fistulas, cartilage defects, and chronic pancreatitis.

Gene therapy

Gene-modified stem cell therapies are being investigated for their potential in treating genetic disorders, metabolic diseases, and certain types of cancer. For example, genetically modified hematopoietic stem cells may be used to treat inherited blood disorders like sickle cell disease or beta-thalassemia.

Neuroprotection and neuroregeneration

Clinical trials are studying stem cell therapies for their potential to protect and regenerate neurons in neurodegenerative diseases and neurological injuries. This includes approaches such as transplantation of neural stem cells or mesenchymal stem cells, as well as promoting endogenous neurogenesis and synaptic repair.

Eligibility and participation in stem cells clinical trials

Eligibility for stem cells clinical trials varies widely, targeting specific diseases, age groups, and health conditions. Trials may be open to individuals with specific diagnoses, such as leukemia, Alzheimer's disease, or organ-specific injuries. Criteria often include the stage of the disease, previous treatments, and overall health status.

What to expect when participating in a stem cells clinical trial

Participants can expect thorough screening for eligibility, comprehensive information about the study's purpose and procedures, and close monitoring throughout the trial. This may involve receiving stem cell infusions, undergoing surgical procedures for tissue transplantation, and participating in follow-up assessments to monitor the therapy's effectiveness and any side effects.

Article preview image

Worried about the risks of participating in a clinical trial? Delve into our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.

Clinical Trial Benefits, Risks & Safety Considerations

How to enroll in a stem cell clinical trial

Enrolling in a stem cell clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:

  1. Identify Your Trial: Use our search function or filters to find clinical trials that match your medical condition and interest in stem cell therapy. This first step simplifies the process of finding relevant research studies tailored to your needs.
  2. Select Your Preferred Location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
  3. Explore Study Details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
  4. Complete the Health Profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
  5. Submit the Application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.